Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer
Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer
The purpose of this study is to evaluate the feasibility of complete nerve-sparing type C1
 radical hysterectomy in cervical cancer.
The primary objective of this study is to evaluate the rate of postvoid residual urine volume
 (PVR) <50ml on postoperative day 4 in patients with stage IB1 and IIA1 cervix cancer
 underwent complete nerve-sparing type C1 radical hysterectomy.
Inclusion Criteria:

 -  Age >=18 years to <= 70 years.

 -  Women with histologically confirmed, primary adenocarcinoma or squamous cell carcinoma
 of the uterine cervix.

 -  Stage IIA1, or IB1 disease.

 -  Karnofsky performance status >70.

 -  Patients who comply with follow-up.

 -  With written informed consent.

 Exclusion Criteria:

 -  Age>70

 -  History of lower urinary tract damage or surgery.

 -  With abnormal urodynamic study results.

 -  Karnofsky performance status <70.

 -  Patients who have uncontrolled psychological disorders.

 -  Unwilling to or unable to comply with protocol.

 -  Prior treatment with pelvic radiotherapy